Cargando…
An Alternative Macrophage Activation Pathway Regulator, CHIT1, May Provide a Serum and Synovial Fluid Biomarker of Periprosthetic Osteolysis
BACKGROUND: Periprosthetic osteolysis (PPO) is a frequent indication for total hip replacement (THR) failure. Currently, PPO diagnosis occurs in advanced stages that often necessitate complex revisions due to bone loss. PPO biomarkers could facilitate earlier diagnosis. Alternative macrophage activa...
Autores principales: | Trehan, Samir K., Zambrana, Lester, Jo, Jonathan E., Purdue, Ed, Karamitros, Athanos, Nguyen, Joseph T., Lane, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031547/ https://www.ncbi.nlm.nih.gov/pubmed/29983656 http://dx.doi.org/10.1007/s11420-017-9598-9 |
Ejemplares similares
-
Pyroptosis in Periprosthetic Osteolysis
por: Yin, Jian, et al.
Publicado: (2022) -
Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment
por: Goodman, Stuart B., et al.
Publicado: (2019) -
The dual role of autophagy in periprosthetic osteolysis
por: Yin, Zhaoyang, et al.
Publicado: (2023) -
Management of Periprosthetic Osteolysis after Total Ankle Arthroplasty
por: Park, Yoo Jung, et al.
Publicado: (2020) -
Hip prosthetic loosening and periprosthetic osteolysis: A commentary
por: Mjöberg, Bengt
Publicado: (2022)